FDA Drug Application (021924) for TIROSINT by INSTITUT BIOCHIMIQUE

Back to FDA Applications sponsored by INSTITUT BIOCHIMIQUE

Application Number021924
Product Number002
FormCAPSULE;ORAL
Dosage0.025MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTIROSINT
Active IngredientLEVOTHYROXINE SODIUM



Back to FDA Applications sponsored by INSTITUT BIOCHIMIQUE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.